Ontology highlight
ABSTRACT: Introduction
Metastatic gastroesophageal adenocarcinoma (GEA) is a heterogeneous disease with an overall poor prognosis. The impact of sites of metastatic dissemination on survival is not well characterized. This study aimed to evaluate whether certain sites of metastatic disease impacts survival.Methods
A retrospective analysis of 375 patients with metastatic GEA treated at the Princess Margaret Cancer Centre from 2006 to 2016 was performed. Overall survival (OS) and progression-free survival (PFS) were estimated using the Kaplan-Meier method. Cox proportional hazards regression models were used to assess the association between sites of metastases and OS adjusting for baseline patient characteristics.Results
Median duration of follow-up was 47.8 months. Median OS
SUBMITTER: Wang X
PROVIDER: S-EPMC9533436 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature